Form 8-K - Current report:
SEC Accession No. 0001104659-20-104452
Filing Date
2020-09-11
Accepted
2020-09-11 16:47:02
Documents
1
Period of Report
2020-08-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a20-30715_18k.htm 8-K 31493
  Complete submission text file 0001104659-20-104452.txt   32808
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 201171444
SIC: 2834 Pharmaceutical Preparations